Bill Eldridge

Bill Eldridge is an accomplished scientist with extensive experience in biotherapeutic discovery and development. Currently serving as CEO and Chief Scientific Officer at Isogenica Limited since August 2020, Bill Eldridge has previously held roles including Senior Director of Alliances and Consultant at B. Eldridge Consulting. Prior to Isogenica, Bill Eldridge was Chief Scientific Officer at Cyclogenix Limited, focusing on developing cyclic peptides and antibodies. Bill Eldridge's career began at Cambridge Antibody Technology, where expertise in antibody engineering was honed. An academic background includes a PhD in Protein Engineering from the University of Kent and a BSc in Microbiology from the University of Surrey.